Statera BioPharma (STAB) Financial Statements

191 Followers

Statera BioPharma Financial Overview

Statera BioPharma's market cap is currently $14.28K. The company's EPS TTM is $-2.613; its P/E ratio is ―; Statera BioPharma is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -488.31K	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Operating Income	$ -98.34M	$ -10.50M	$ -2.81M	$ -4.80M	$ -5.60M
EBITDA	$ -170.65M	$ -10.96M	$ -3.09M	$ -4.80M	$ -5.60M
Net Income	$ -174.41M	$ -13.22M	$ -3.35M	$ -3.61M	$ -9.71M
Balance Sheet
Cash & Short-Term Investments	$ 1.98M	$ 593.87K	$ 1.58M	$ 4.12M	$ 8.79M
Total Assets	$ 21.17M	$ 1.04M	$ 1.65K	$ 4.53M	$ 9.63M
Total Debt	$ 16.26M	$ 2.00M	$ 1.80M	$ 0.00	$ 0.00
Net Debt	$ 14.42M	$ 1.41M	$ 1.80M	$ -3.62M	$ -4.23M
Total Liabilities	$ 22.68M	$ 4.69M	$ 1.52M	$ 920.38K	$ 2.22M
Stockholders' Equity	$ -1.57M	$ -3.66M	$ -4.21M	$ -1.45M	$ 2.20M
Cash Flow
Free Cash Flow	$ -28.38M	$ -5.09M	$ -240.37K	$ -4.61M	$ -6.61M
Operating Cash Flow	$ -28.19M	$ -5.08M	$ -240.37K	$ -4.61M	$ -6.61M
Investing Cash Flow	$ 13.46M	$ -9.64K	$ 156.78K	$ 3.97M	$ 3.89M
Financing Cash Flow	$ 20.99M	$ 5.68M	$ 231.00K	$ 55.22K	$ 0.00

Currency in USD

Statera BioPharma Earnings and Revenue History

Income Statement >

Statera BioPharma Debt to Assets

Balance Sheet >

Statera BioPharma Cash Flow

Cash Flow >

Statera BioPharma Forecast EPS vs Actual EPS

Earnings >